Shanghai Bio-heart Biological Technology Co., Ltd. (HKG:2185)
Hong Kong · Delayed Price · Currency is HKD 3.960
-0.030 (-0.75%)
At close: Mar 27, 2026
HKG:2185 Market Cap
HKG:2185 has a market cap or net worth of 963.93 million as of March 27, 2026. Its market cap has increased by 72.17% in one year.
Market Cap
963.93M
Enterprise Value
898.82M
Revenue
50.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.96
Market Cap Chart
Since December 23, 2021, HKG:2185's market cap has decreased from 4.90B to 963.93M, a decrease of -80.34%. That is a compound annual growth rate of -31.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 963.93M | -31.61% |
| Dec 31, 2025 | 1.41B | 253.05% |
| Dec 31, 2024 | 399.20M | -52.05% |
| Dec 29, 2023 | 832.49M | -41.56% |
| Dec 30, 2022 | 1.42B | -78.41% |
| Dec 31, 2021 | 6.60B | 34.58% |
| Dec 23, 2021 | 4.90B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CANbridge Pharmaceuticals | 1.55B |
| Beijing Biostar Pharmaceuticals | 1.40B |
| Kintor Pharmaceutical | 1.37B |
| Brii Biosciences | 1.01B |
| 3D Medicines | 993.81M |
| Sunho Biologics | 971.95M |
| Transcenta Holding | 971.77M |
| Wuhan YZY Biopharma | 800.60M |